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Mental disorders around cancer diagnosis
and increased hospital admission rate - a
nationwide cohort study of Swedish cancer
patients
Jianwei Zhu1* , Arvid Sjölander1, Katja Fall1,2, Unnur Valdimarsdottir1,3,4 and Fang Fang1
Abstract
Background: Whether the emotional distress around cancer diagnosis is associated with the long-term outcomes
and care utilization is unknown. We aimed to examine the association of mental disorders around cancer diagnosis
with the hospital admission rates of cancer patients thereafter.
Methods: We conducted a nationwide cohort study including 218,508 cancer patients diagnosed in Sweden during
2004–2009 and followed them from 90 days after cancer through 2010. We used a clinical diagnosis of stress-related
mental disorders from 90 days before to 90 days after cancer diagnosis as the exposure. We studied first all hospital
admissions and then separately three common admissions, including external injuries, infections, and cardiovascular
diseases. The Cox model was used to estimate hazard ratios (HRs) with 95% confidence intervals (CIs).
Results: Four thousand one hundred five patients received a diagnosis of stress-related mental disorders around
the cancer diagnosis, and experienced a 35% increased rate of any hospital admission during follow-up (HR: 1.
35, 95%CI: 1.28–1.41) as well as hospital admissions for external injuries (HR: 1.89, 95%CI: 1.67–2.14), infections
(HR: 1.28, 95%CI: 1.08–1.52), and cardiovascular diseases (HR: 1.16, 95%CI: 1.03–1.30). Similar association was
noted for most common cancer types.
Conclusions: These data suggest that cancer patients diagnosed with a stress-related mental disorder
immediately before or after cancer diagnosis are subsequently at increased risk of hospital admissions for major
comorbidities of cancer.
Keywords: Mental disorder, Cancer, Hospital admission, Comorbidity, Survival analysis
Background
The diagnostic work-up for a suspected cancer finally
leading to a definite cancer diagnosis is a highly stressful
period for patients. Indeed, a considerable increase in a
range of psychiatric disorders, including depression, anx-
iety, and other stress-related reactions has been observed
among cancer patients during the months before [1–3]
and after [1, 4] cancer diagnosis. In addition to the swift
deterioration in the psychological spheres of the patients’
quality of life, it is possible that this rise in psychiatric
disorders around the time of cancer diagnosis leads to
further health consequences during the disease course.
Psychiatric disorders in the general population have
been associated with elevated risks of injuries [5], cardio-
vascular diseases [6] and increased susceptibility for infec-
tions [7], with corresponding increase in healthcare use
and medical costs [8]. Although these associations have
not to date been specifically explored among cancer
patients, our previous studies indicate that the rise in psy-
chiatric disorders around the cancer diagnosis [1] coin-
cides with a rise in infections and injuries [9] as well as
cardiovascular diseases [10]. In our most recent work, we
documented an increased risk of cancer-specific mortality
among patients with first-onset psychiatric disorders in
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response to their cancer diagnosis [11]. Similarly, we here
aim to explore the potential impact of mental disorders
diagnosed immediately before or after a cancer diagnosis
on the subsequent rate of hospital admissions for com-
mon comorbidities of cancer - namely, external injuries,
infections, and cardiovascular diseases.
Methods
Study design
We conducted a prospective cohort study based on the
Swedish Cancer Register, including all adult patients
(30 years and above) with a first primary cancer diag-
nosed between January 1st 2004 and December 31st
2009 (N = 251,214). Information available in this register
includes date of and age at diagnosis, sex, cancer type,
cancer stage, and the Swedish national identity number.
Cancer types were coded according to the 7th Swedish
revision of the International Classifications of Diseases
(ICD) codes [12]. Since 2004, the register has also col-
lected relatively complete information on cancer stage at
the time of diagnosis, except for hematological cancers
and central nervous system (CNS) tumors. Patients with
CNS tumors (N = 6061) were not included in the present
study because the occurrence of mental disorders among
these patients might be physiologically related to the
lesion of the CNS [13, 14]. Patients that had emigrated
before cancer diagnosis (N = 6255) were excluded from
the study cohort. The individually unique national iden-
tify numbers, assigned to all Swedish residents, allowed
record linkages between the study cohort and other
nationwide population and health registers [15].
Ascertainment of mental disorders
Mental disorders were ascertained by cross-linking all
cancer patients to the Swedish Patient Register. In
Sweden, all hospital discharge records have been col-
lected in the Patient Register since 1987 and > 80% of
outpatient visits for hospital-based specialist care since
2001 [16]. In this register, all diagnoses are coded from
1997 according to the 10th Swedish revision of the ICD
codes. We focused on the mental disorders that are
commonly diagnosed among cancer patients [17], for
which highly increased risks have been reported immedi-
ately before and after cancer diagnosis [1]. We included
depression (ICD10: F30-F39), anxiety (ICD10: F40-F41),
stress reaction or adjustment disorder (ICD10: F43),
mental and behavioral disorders due to psychoactive
substance use (ICD10: F10-F16, F18-F19), and somato-
form/conversion disorder (ICD10: F44-F45). Because
these disorders have been suggested as potentially re-
lated to severe psychological stress [18–21], we used
“stress-related mental disorders” as a collective term for
all the selected disorders.
In Sweden, the median waiting time, between the
first referral to a specialist and the start of cancer
treatment, is around 2 months [22]. The symptoms of
cancer, as well as the suspicion of a potential cancer
disease, probably start even earlier than the first refer-
ral for most patients. The psychological distress in re-
lation to these might be reflected by the increasing
risk of stress-related mental disorders during the
10 months before cancer diagnosis, especially during
the months immediately before and after cancer diag-
nosis [1]. We therefore aimed to use stress-related
mental disorders as indices of severe stress response
toward the cancer diagnostic process and the eventual
diagnosis. We used a hospital visit, whether inpatient
or outpatient, with a stress-related mental disorder as
either the primary or a secondary diagnosis from
90 days before to 90 days after cancer diagnosis as the
primary exposure of interest. We used all other mental
disorders, including organic (ICD10: F00–09), tobacco
abuse (ICD10: F17), schizophrenia (ICD10: F20–29),
affective (ICD10: F30–31/F34–39), neurotic (ICD10:
F42/48), physiological/physical factors related (ICD10:
F50–59), personality (ICD10: F60–69), retardation
(ICD10: F70–79), psychological development (ICD10:
F80–89), and unspecified (ICD10: F90–99) disorders
from 90 days before to 90 days after cancer diagnosis
as the secondary exposure.
We categorized cancer patients with no hospital visit
for any mental disorders during this time window as the
reference group.
Ascertainment of hospitalizations after cancer diagnosis
We followed all cancer patients from 90 days after diagno-
sis until death or December 31st 2010, whichever oc-
curred first. Patients who died within the first 90 days
after their cancer diagnosis were excluded, leaving 218,508
patients (91.47%) in the final analyses. Hospital admissions
of these patients during follow-up were also identified
from the Patient Register. Information on dates of admis-
sion and discharge, as well as the main discharge diagnosis
of each hospitalization was retrieved. Consecutive hospital
admissions were treated as one admission event. We first
performed analysis for any hospital admission as a
proxy for overall healthcare utilization. We then per-
formed separate analyses for three types of common
hospital admissions, including external injuries (ICD10:
S00-S99, T00-T36, T51-T79, T89-T95, T97-T98.2, T98.
4-T99) - both unintentional injuries (ICD10: V01-X59,
Y85-Y86) and self-harm (ICD-10: X60-X84,Y870) [9],
infections (ICD10: A00-A99, B00-B99), and cardiovas-
cular diseases (CVD, ICD10: I00-I99), as well as for
hospital admissions of different durations (< 4 days,
4–10 days, and > 10 days).
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Statistical analysis
We used Cox regression to assess the association of
mental disorders diagnosed from 90 days before to
90 days after a cancer diagnosis with the subsequent rate
of hospital admissions. Because patients might be re-
peatedly admitted, a clustered sandwich estimator was
used to account for intra-individual correlation. We per-
formed the analysis first for all cancer patients (exclud-
ing patients with hematological cancers because we
adjusted for cancer stage in this analysis and cancer
stage is not applicable for these patients) and then separ-
ately for patients with the most common cancer types,
including breast, prostate, colorectal, lung, melanoma,
kidney or bladder, and hematological cancers. Esophageal,
liver, and pancreatic cancers were combined into one
group of severe cancers.
In all statistical models, we used age at follow-up as
the underlying timescale and adjusted for age at cancer
diagnosis (as a continuous variable), sex, calendar year
of cancer diagnosis (as a continuous variable), cancer
type (see Additional file 1: Table S1), cancer stage at
diagnosis (except for hematological cancers), educational
level (≥9 years or < 9 years), and history of mental disor-
ders more than 90 days before cancer diagnosis (yes or
no). In the analysis of hematological cancers, we further
adjusted for cancer subtype, including Hodgkin lymph-
oma, non-Hodgkin lymphoma, myeloma, and leukemia.
Information on cancer stage was ascertained by the
TNM or FIGO records from the Cancer Register, includ-
ing localized (T-localized/N0/M0 or FIGO 0, I), local
spread (T-advanced/N0/M0 or FIGO II), regional spread
(any T/N+/M0 or FIGO III), advanced (any T/any N/M
+ or FIGO IV), and unknown cancers. History of any
mental disorders more than 90 days before cancer diag-
nosis was ascertained from the Patient Register. Patients
with at least one hospital visit (inpatient or outpatient)
concerning a mental disorder from year 2001 to 90 days
before cancer diagnosis were classified as having a
history of mental disorder.
To assess potential effect modifiers of the studied
associations, we further stratified the analyses by age
group (≤65, 66–75, and > 75 years), sex, calendar period
of diagnosis (2004–2006, 2007–2009), cancer stage, edu-
cational level, and history of mental disorders. We
assessed the statistical significance of these effect modifi-
cations by introducing interaction terms between the
exposure and these variables to the Cox regression.
Mental disorders around the time of cancer diagnosis
could be associated with the type of cancer treatment,
leading to different hospital admission rates later on. We
therefore performed a sensitivity analysis for cancers
commonly treated by surgeries, including prostate, lung,
and colorectal cancers. We repeated the main analyses
for these cancers, after additionally adjusting for surgical
treatment (yes or no). To explore the role of individual
stress-related mental disorders, we performed separate
analysis on the risk of hospital admissions in relation to
different stress-related mental disorders around cancer
diagnosis. Finally, to assess whether the results were
sensitive to the choice of exposure time window and the
inclusion of patients with previous mental disorders, we
performed a sensitivity analysis including only cancer pa-
tients without any mental disorders before cancer diagno-
sis and using only mental disorders diagnosed during the
90 days after cancer diagnosis as the exposure.
All the statistical analyses were carried out in SAS9.4
(SAS Institute, North Carolina, United States) and
Stata14.4 (StataCorp LP).
Results
From 90 days before to 90 days after cancer diagno-
sis, 4105 patients (1.88%) had a hospital visit concern-
ing a stress-related mental disorder and 3594 (1.64%)
had a hospital visit concerning other mental disorders
(Table 1).
Cancer patients with a stress-related mental disorder
around cancer diagnosis had greater number of hospital
admissions during follow-up (median: 2; range: 0–68),
compared to patients with other mental disorders (me-
dian: 1; range: 0–75) or without any mental disorders
(median: 1; range: 0–57) (p < 0.01, Table 2) around can-
cer diagnosis. Similar differences were observed for most
of the common cancers, including prostate, breast, colo-
rectal, renal and bladder, and hematological cancers.
Compared to the unexposed group, patients with a
stress-related mental disorder around cancer diagnosis
had a 35% increased rate of any hospital admission dur-
ing follow-up; whereas patients with a hospital visit for
other mental disorders had a 7% increased rate (Table 3).
Both rate increases were more pronounced for hospital
admissions of > 10 days’ duration compared to admis-
sions of shorter durations. For stress-related mental dis-
orders, the increased rate was highest for external
injury-related hospitalizations (unintentional injuries:
hazard ratio [HR] = 1.85, 95% confidence interval [CI]: 1.
62–2.12; intentional injuries: HR = 6.64, 95%CI: 1.09–40.
31), followed by infection-related, and cardiovascular
disease-related hospitalizations. For other mental disor-
ders, an increased rate was noted for external injury-
related and infection-related hospitalizations.
A stress-related mental disorder around cancer diagno-
sis was associated with an increased rate of hospital ad-
mission among almost all cancer types although the
associations were not statistically significant for melanoma
and severe cancers (Table 4). Statistically significantly in-
creased rate of hospital admission for external injuries was
noted for all cancer types except melanoma, lung and
severe cancers. Statistically significantly increased rate of
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hospital admission for infections was observed for breast,
colorectal, and hematological cancers, whereas statistically
significantly increased rate of hospital admissions for car-
diovascular diseases was only noted for colorectal cancer.
The magnitude of the estimated associations were
similar for all patients, regardless of age, sex, calendar
period, educational level, history of mental disorders, or
cancer stage (Table 5). However, we did observe a statis-
tically significant difference between sexes, with stronger
associations for the males, for any hospital admission,
hospital admission for external injuries, and hospital
admission for cardiovascular diseases (all P-values for
interaction: < 0.05). We also observed statistically signifi-
cant differences across age groups, with stronger associ-
ations for the young patients, for any hospital admission
and for hospital admission for external injuries (both
P-values for interaction: < 0.05). Finally, we observed
statistically significant differences across cancer stages,
with stronger associations for early stages, for any
hospital admission (P-value for interaction: < 0.01),
although similar patterns were not clear for hospital
admissions for specific reasons.
In the additional analysis of prostate, lung, and colo-
rectal cancers, we found similar risk elevations of
hospital admission by stress-related mental disorders
after adjustment for surgical treatment (Additional file 1:
Table S2). We further found increased rates of hospital
admissions for all individual stress-related mental disor-
ders studied (Additional file 1: Table S3). In the sensitiv-
ity analysis for patients without a history of mental
disorders before cancer diagnosis, we found very similar
associations between mental disorders during the
90 days after cancer diagnosis and increased rate of
hospital admission thereafter, as in the main analysis
(Additional file 1: Table S4).
Discussion
In this nationwide cohort study we found that a diagno-
sis of stress-related mental disorders immediately before
and after cancer diagnosis was associated with increased
healthcare utilization and morbidity of the cancer pa-
tients, indexed by an increased rate of hospital admis-
sion. The increased rate was mostly attributable to
hospital admissions for external injuries, infections, and
cardiovascular diseases. The increased rate was also
more pronounced for admissions of longer duration and
did not differ by age, sex, calendar period, history of
mental disorders, or cancer stage. Although other men-
tal disorders around cancer diagnosis were also associ-
ated with a slightly higher rate of hospital admission, the
magnitude of rate increase was considerably smaller.
To the best of our knowledge, our study represents
the first large-scale investigation to evaluate the influ-
ence of a severe stress response during the diagnostic
process of cancer on the rate of any hospital admission -
as a proxy for overall healthcare use - including admis-
sions for injuries, infections, and cardiovascular diseases.
A statistically significantly increased rate for hospital
admission was noted for all major cancer types, except
for melanoma and cancers with poor prognosis. The rea-
son for the null findings among patients with melanoma
and severe cancers is not entirely clear, although lack of
statistical power in detecting real associations due to the
small numbers of patients included in the analyses and
the relatively short follow-up might be a partial explan-
ation. The modestly increased rate of hospital admission
due to other mental disorders around cancer diagnosis,
in comparison to stress-related mental disorders, might
suggest that a severe stress response to cancer diagnosis
Table 1 Baseline characteristics of 218,508 cancer patients that
were diagnosed during 2004–2009 in Sweden, N (%)
Unexposed
patients
Stress-related
mental disordersa
Other mental
disordersb
Sex
Male 113,099 (53.65) 1845 (44.95) 1688 (46.97)
Female 97,710 (46.35) 2260 (55.05) 1906 (53.03)
Age at diagnosis, years
≤ 65 89,975 (42.68) 2303 (56.10) 1162 (32.33)
66–75 60,538 (28.72) 996 (24.26) 822 (22.87)
> 75 60,296 (28.60) 806 (19.63) 1610 (44.80)
Calendar period at diagnosis
2004–2006 104,917 (49.77) 1870 (45.55) 1531 (42.60)
2007–2009 105,892 (50.23) 2235 (54.45) 2063 (57.40)
Educational level
> 9 years 126,879 (60.19) 2547 (62.05) 1787 (49.72)
≤ 9 years 83,686 (39.70) 1550 (37.76) 1804 (50.19)
Missing 244 (0.12) 8 (0.19) 3 (0.083)
Previous mental disorders
No 201,345 (95.51) 2147 (52.30) 1876 (52.20)
Yes 9464 (4.49) 1958 (47.70) 1718 (47.80)
Cancer stagec
Localized 98,192 (46.58) 1550 (37.76) 1273 (35.42)
Local spread 26,512 (12.58) 535 (13.03) 540 (15.03)
Regional spread 23,368 (11.08) 636 (15.49) 568 (15.80)
Advanced 15,981 (7.58) 369 (8.99) 324 (9.02)
Unknown 33,022 (15.66) 710 (17.30) 664 (18.48)
Not applicable 13,734 (6.51) 305 (7.43) 225 (6.26)
aStress-related mental disorders included depression, anxiety, stress reaction
and adjustment disorder, mental and behavioral disorders due to psychoactive
substance use, and somatoform/conversion disorder
bOther mental disorders included organic, tobacco abuse, schizophrenia,
affective, neurotic, physiological/physical factors related, personality,
retardation, psychological development, and unspecified disorders
cPatients with missing or unclear information of TNM/FIGO were classified as
‘Unknown’. Hematological cancers were classified as ‘Not applicable’
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leads to additionally increased inpatient care use, relative
to impaired mental health in general. Taken together,
these findings suggest that stress-related mental disor-
ders experienced in close vicinity of cancer diagnosis, as
indices of a severe stress response toward the cancer
diagnostic process and the diagnosis itself, could lead to
increased need for healthcare use and comorbidities,
independently of previous mental health status.
Patients with stress-related disorders around the diag-
nosis of almost all cancer types presented with increased
rates of hospital admissions for external injuries, except
for melanoma. The stronger associations noted for
intentional injuries, compared to unintentional injuries,
corroborate and might partly underline earlier findings
that cancer patients had increased risks for self-harm in-
cluding suicide [10]. The clear although slightly weaker
associations noted for unintentional injuries are worth
noting. Possible underling mechanisms for such associa-
tions might include mental distress and worsening of so-
cial and physical function in relation to stress-related
mental disorders. Finally, both the cognitive impairment
and psychiatric symptoms of mental disorders may
further contribute to the occurrence of unintentional
injuries [23].
An increased rate of infection-related hospital ad-
mission was found for stress-related mental disorders
around cancer diagnosis. The association was noted
for most cancer types, except prostate and lung can-
cers, and did not differ clearly by age, sex, calendar
period, educational level, history of mental disorders,
or cancer stage. A similar association was noted for
other mental disorders around cancer diagnosis, al-
though with slightly smaller magnitude of rate in-
crease. These findings are indeed biologically plausible.
Depression and anxiety have been shown to directly
affect the immune system by for example regulating
the secretion of pro-inflammatory cytokines [24], and
subsequently regulating the response to infections.
Psychological stress has specifically been linked with
impaired immune response to infectious challenges,
leading to increased risk for contagion and prolonged
infection episodes [25–27]. Among cancer patients
with surgical treatments, psychological stress might
also lead to delayed wound healing [28] and increased
risk for wound infection [29].
Table 3 Associations of mental disorders around cancer
diagnosis with hospital admission, among all cancer patients
Stress-related mental
disorders; HR (95% CI)a
Other mental disordersb;
HR (95% CI)
Any hospital
admission
1.35 (1.28–1.41) 1.07 (1.01–1.13)
Duration of admission
< 4 days 1.25 (1.18–1.33) 1.01 (0.93–1.10)
4–10 days 1.32 (1.25–1.40) 1.04 (0.98–1.10)
> 10 days 1.63 (1.53–1.73) 1.24 (1.15–1.33)
Main discharge diagnosis
External injury 1.89 (1.67–2.14) 1.36 (1.20–1.55)
Infection 1.28 (1.08–1.52) 1.19 (1.00–1.42)
Cardiovascular
disease
1.16 (1.03–1.30) 0.91 (0.80–1.03)
aStress-related mental disorders included depression, anxiety, stress reaction
and adjustment disorder, mental and behavioral disorders due to psychoactive
substance use, and somatoform/conversion disorder; HR Hazard ratio, CI
Confidence interval; models adjusted for age at cancer diagnosis, sex, calendar
period of cancer diagnosis, cancer type, cancer stage at diagnosis, educational
level, and history of mental disorders more than 90 days before cancer
diagnosis; patients without any mental disorders from 90 days before to
90 days after cancer diagnosis were used as the reference group
bOther mental disorders included organic, tobacco abuse, schizophrenia,
affective, neurotic, physiological/physical factors related, personality,
retardation, psychological development, and unspecified disorders
Table 2 Number of hospital admissions during follow-up
All patients Unexposed patients Stress-related mental disordersa Other mental disordersb
N N Median (Range) N Median (Range) N Median (Range) Pd
Any cancer 218,508 210,809 1 (0–57) 4105 2 (0–68) 3594 1 (0–75) < 0.01
Prostate cancer 50,393 49,458 1 (0–45) 521 2 (0–33) 414 1 (0–20) < 0.01
Breast cancer 33,734 32,466 1 (0–45) 706 1 (0–37) 562 1 (0–18) < 0.01
Lung cancer 12,676 11,932 2 (0–57) 338 2 (0–31) 406 2 (0–18) 0.31
Colorectal cancer 25,733 24,650 1 (0–43) 518 2 (0–68) 565 1 (0–75) < 0.01
Melanoma 10,905 10,695 0 (0–27) 125 1 (0–14) 85 1 (0–10) < 0.01
Hematological cancers 14,264 13,734 2 (0–43) 305 2 (0–28) 225 1 (0–30) < 0.01
Renal/Bladder cancer 14,666 14,093 2 (0–36) 277 2 (0–28) 296 2 (0–22) < 0.05
Severe cancersc 4223 3989 2 (0–38) 135 1 (0–19) 99 1 (0–17) < 0.01
a Stress-related mental disorders included depression, anxiety, stress reaction and adjustment disorder, mental and behavioral disorders due to psychoactive
substance use, and somatoform/conversion disorder
b Other mental disorders included organic, tobacco abuse, schizophrenia, affective, neurotic, physiological/physical factors related, personality, retardation,
psychological development, and unspecified disorders
c Severe cancers included esophageal, liver, and pancreatic cancers
d Nonparametric tests were used to test the median and range differences
Zhu et al. BMC Cancer  (2018) 18:322 Page 5 of 9
Table 5 Associations of stress-related mental disorders around cancer diagnosis with hospital admission, a stratification analysisa
Main discharge diagnosis of hospital admission
Any hospital admission; HR (95% CI)b External injury; HR (95% CI) Infection; HR (95% CI) Cardiovascular disease; HR (95% CI)
Sex
Male 1.42 (1.32–1.52) 2.12 (1.76–2.55) 1.35 (1.05–1.72) 1.25 (1.06–1.47)
Female 1.28 (1.20–1.37) 1.68 (1.43–1.97) 1.24 (0.98–1.57) 1.05 (0.89–1.23)
Age at follow-up, years
≤ 65 1.36 (1.27–1.45) 1.99 (1.56–2.53) 1.44 (1.11–1.87) 1.20 (0.96–1.51)
66–75 1.36 (1.25–1.49) 1.85 (1.47–2.34) 0.98 (0.72–1.35) 1.19 (0.94–1.52)
> 75 1.21 (1.11–1.31) 1.62 (1.36–1.94) 1.25 (0.92–1.70) 1.01 (0.86–1.19)
Calendar period at diagnosis
2004–2006 1.34 (1.25–1.44) 1.84 (1.57–2.17) 1.15 (0.91–1.45) 1.11 (0.96–1.30)
2007–2009 1.36 (1.28–1.45) 1.93 (1.61–2.31) 1.42 (1.11–1.83) 1.25 (1.03–1.52)
Educational level
> 9 years 1.34 (1.26–1.43) 1.96 (1.66–2.32) 1.29 (1.04–1.59) 1.09 (0.93–1.29)
≤ 9 years 1.36 (1.27–1.46) 1.75 (1.47–2.08) 1.28 (0.96–1.69) 1.20 (1.01–1.43)
Previous mental disorders
No 1.32 (1.24–1.41) 1.86 (1.55–2.22) 1.40 (1.11–1.76) 1.01 (0.86–1.19)
Yes 1.34 (1.25–1.43) 1.82 (1.53–2.15) 1.12 (0.87–1.43) 1.28 (1.06–1.53)
Cancer stagec
Localized 1.48 (1.37–1.60) 2.01 (1.67–2.42) 1.15 (0.86–1.55) 1.21 (1.01–1.45)
Local spread 1.27 (1.12–1.43) 1.92 (1.46–2.52) 1.44 (0.95–2.17) 1.36 (1.02–1.82)
Regional spread 1.23 (1.12–1.37) 1.48 (1.06–2.06) 1.03 (0.67–1.61) 1.35 (1.01–1.79)
Advanced 1.08 (0.95–1.22) 1.52 (0.94–2.45) 1.52 (0.80–2.87) 0.78 (0.51–1.21)
Unknown 1.42 (1.27–1.60) 2.07 (1.56–2.73) 0.99 (0.65–1.50) 0.97 (0.73–1.29)
aStress-related mental disorders included depression, anxiety, stress reaction and adjustment disorder, mental and behavioral disorders due to psychoactive
substance use, and somatoform/conversion disorder
bHR Hazard ratio, CI Confidence interval; models adjusted for age at cancer diagnosis, sex, calendar period of cancer diagnosis, cancer type, cancer stage at
diagnosis, educational level, and history of mental disorders more than 90 days before cancer diagnosis; patients without any mental disorders from 90 days
before to 90 days after cancer diagnosis were used as the reference group
cPatients with missing or unclear information of TNM/FIGO were classified as ‘Unknown’
Table 4 Associations of stress-related mental disorders around cancer diagnosis with hospital admission, among different cancer typesa
Cancer types Main discharge diagnosis of hospitalization
Any hospital admission; HR
(95% CI)b
External injury; HR
(95% CI)
Infection; HR
(95% CI)
Cardiovascular disease; HR
(95% CI)
Prostate cancer 1.56 (1.39–1.76) 2.33 (1.71–3.18) 0.91 (0.58–1.45) 1.15 (0.87–1.52)
Breast cancer 1.44 (1.28–1.61) 1.54 (1.18–2.01) 1.51 (1.05–2.17) 1.29 (0.99–1.69)
Lung cancer 1.30 (1.13–1.49) 1.43 (0.84–2.41) 0.72 (0.37–1.40) 0.99 (0.66–1.48)
Colorectal cancer 1.46 (1.27–1.68) 1.89 (1.44–2.49) 1.60 (1.08–2.39) 1.39 (1.06–1.83)
Melanoma 1.05 (0.79–1.40) 0.96 (0.42–2.21) NA 1.41 (0.83–2.40)
Hemetological cancers 1.42 (1.22–1.65) 1.99 (1.26–3.16) 1.47 (1.05–2.07) 0.97 (0.66–1.44)
Renal/Bladder cancer 1.37 (1.16–1.61) 2.01 (1.31–3.07) 1.54 (0.98–2.42) 1.15 (0.78–1.71)
Severe cancersc 1.13 (0.93–1.37) 1.12 (0.38–3.36) 1.87 (0.81–4.35) 1.17 (0.57–2.41)
aStress-related mental disorders included depression, anxiety, stress reaction and adjustment disorder, mental and behavioral disorders due to psychoactive
substance use, and somatoform/conversion disorder
bHR Hazard ratio, CI Confidence interval; models adjusted for age at cancer diagnosis, sex, calendar period of cancer diagnosis, cancer type, cancer stage at
diagnosis, educational level, and history of mental disorders more than 90 days before cancer diagnosis; patients without any mental disorders from 90 days
before to 90 days after cancer diagnosis were used as the reference group
cSevere cancers included esophageal, liver, and pancreatic cancers
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Increased risk for cardiovascular diseases, including
coronary artery disease and stroke, have been related to
various stress-related mental disorders including depres-
sion [30, 31] and anxiety [32, 33]. We observed positive
association between stress-related mental disorders
around cancer diagnosis and increased rate of cardiovas-
cular disease-related hospital admission, regardless of
patient or cancer characteristics. A positive association
was also noted for most cancer types, with the exception
of lung and hematological cancers, perhaps because of
the high baseline rate of cardiovascular diseases among
these two cancer groups [34, 35]. Interestingly, the in-
creased rate of cardiovascular disease-related hospital
admission appeared to be restricted to stress-related
mental disorders, whereas no increased rate was noted
for other mental disorders from 90 days before to 90 days
after cancer diagnosis, further highlighting the fact that
it might be the severe stress response, relative to im-
paired mental health in general, which led to increased
burden of cardiovascular diseases.
The major strength of our study is the large-scale
population-based cohort design, the complete follow-up,
and the prospectively and independently collected data
on mental disorders, cancer, and hospital admissions
after cancer diagnosis, minimizing most of the selection
and information biases commonly seen in observational
studies.
A few limitations should nevertheless be noted. First,
we had no information on other potential confounders,
including for example lifestyle factors (e.g. smoking and
alcohol use) that might be related to both the exposure
and the outcome. However, the similar associations
noted for different cancer types with or without known
links to these lifestyle factors argue against pure explana-
tions by unmeasured confounders. Second, we did not
have detailed information on cancer treatment (e.g. radi-
ation or chemotherapies) and disease progression, which
could both affect hospital admissions. However, in the
sensitivity analysis of prostate, lung, and colorectal can-
cers, we found similar results after further adjustment
for surgical treatment, partially alleviating this concern.
Nevertheless, future studies are needed to disentangle
the potential role of chemo- and radiation therapies in
the associations of stress-related mental disorders and
healthcare utilizations. Third, we used the 90 days before
cancer diagnosis as a proxy for cancer diagnostic
workup, as we had no information on the precise start
of the diagnostic process. Although it is difficult to de-
cide whether or not this is the optimal choice of time
window, the median waiting time between a first special-
ist referral and primary cancer treatment is about 2
months in Sweden [22] and there was highly increased
risk of stress-related mental disorders during the months
immediately before and after cancer diagnosis [1]. Using
a clinical diagnosis of stress-related mental disorders
captures only the tip-of-the-iceberg of the psychological
distress a cancer patient might experience around the
diagnosis of cancer [36–38]. Indeed, only 1.88% cancer
patients of the present study experienced clinically diag-
nosed stress-related mental disorders during 90 days be-
fore to 90 days after cancer diagnosis, whereas previous
studies reported a much higher rate of mental distress
[4] and self-reported or clinically evaluated psychiatric
disorders [39] among cancer patients. This source of
misclassification is however likely to attenuate the real
associations between stress-related mental disorders
around cancer diagnosis and hospital admission rate.
Finally, the present study has an average follow-up of
approximately 3 years, whether or not the studied asso-
ciations would differ during the latter part of cancer
survivorship remains to be explored.
Conclusions
In conclusion, our findings suggest that patients with
stress-related mental disorders immediately before or after
a cancer diagnosis have an increased rate of hospital ad-
missions after cancer diagnosis. The increased need for
hospital admissions among these patients appeared to be
mainly due to common comorbidities, including external
injuries, infections, and cardiovascular diseases. Our find-
ings thus suggest that better psychological management -
through both surveillance and treatment - during the can-
cer diagnostic workup and immediately after the diagnosis
of cancer may help prevent adverse health outcomes and
healthcare unitization among this group of patients.
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